Newsroom Stories

Faculty and staff in the plastic and reconstructive surgery, urologic surgery and public health sciences divisions in the Department of Surgery at Washington University School of Medicine in St. Louis have completed all four levels of training offered by the medical school’s diversity and inclusion team.

Images captured in and around the Washington University campuses.

Infections with one of the most troublesome and least understood antibiotic-resistant “superbugs” are increasing at alarming rates, particularly in health-care settings. But by studying A. baumannii, a frequent cause of difficult-to-treat infections in hospitals,  researchers have identified a naturally occurring​ process that restores its vulnerability to antibiotics.

​Why downsize the O-R-E-O? Joseph Goodman, PhD, associate professor of marketing at Washington University in St. Louis’ Olin Business School, it’s a matter of matching tastes to the market.​​

John A. Cooper, MD, PhD, has been named head of the Department of Biochemistry and Molecular Biophysics at Washington University School of Medicine. 

“World of Warcraft” might not seem like typical research material. But Yulia Nevskaya, PhD, assistant professor of marketing at Olin Business School at Washington University in St. Louis found it the perfect research platform. She has helped lead a study of gamers’ behavior and what’s behind their motivation.

In an effort to increase diversity in the neurosciences, Washington University in St. Louis has received a five-year, $1.5 million federal grant to participate in a national pipeline program with that mission.

Jianmin Cui, PhD, professor of biomedical engineering in the School of Engineering & Applied Science, is taking an innovative approach to finding new drug candidates to treat Long QT syndrome with a four-year, $3.1 million grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health.

The National Cancer Institute (NCI) has awarded Siteman Cancer Center​ at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis an “exceptional” rating, based on a rigorous review of Siteman’s research programs. The rating is the highest possible by the NCI, the principal federal institute that funds cancer research.

Michael L. Stohler, PhD, has been named managing director of asset allocation at the Washington University Investment Management Company – the investment office for the endowment at Washington University. In this capacity, Stohler will play a key role in the overall management of the university’s endowment and other assets.